Andera Partners | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Andera Partners

BRIEF

published on 11/13/2024 at 13:05, 8 days ago

Andera Partners Expands Internationally with New Madrid Office

Private Equity International Expansion Andera Partners Madrid Office Spanish Market
PRESS RELEASE

published on 11/13/2024 at 13:00, 8 days ago

ANDERA PARTNERS CONTINUES ITS INTERNATIONAL EXPANSION AND ANNOUNCES THE OPENING OF A MADRID OFFICE
Andera Partners announces opening of Madrid office for private equity strategy in Spain led by Gonzalo Boada, continuing international expansion

Private Equity International Expansion Andera Partners Madrid Office Gonzalo Boada
BRIEF

published on 07/26/2024 at 09:05, 3 months 26 days ago

Andera Partners Co-Leads $196 Million Round for Kestra Medical

Medical Devices Financing Andera Partners Wearable Defibrillator Raymond W. Cohen
PRESS RELEASE

published on 07/26/2024 at 09:00, 3 months 26 days ago

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors
Andera Partners co-leads $196 million financing round for Kestra Medical, appoints Raymond W. Cohen to the board. Kestra develops a wearable defibrillator vest for cardiac patients

Financing Andera Partners Wearable Defibrillator Raymond W. Cohen Kestra Medical
BRIEF

published on 07/25/2024 at 10:05, 3 months 27 days ago

Andera Partners’ Portfolio Company JenaValve Technology Acquired by Edwards Lifesciences

Acquisition Private Equity FDA Approval Cardiovascular Innovations Heart Valve Technology
PRESS RELEASE

published on 07/25/2024 at 10:00, 3 months 27 days ago

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
Andera Partners' portfolio company JenaValve Technology acquired by Edwards Lifesciences, marking a significant milestone in cardiovascular innovation with FDA approval expected by late 2025

Acquisition Andera Partners Edwards Lifesciences JenaValve Technology Cardiovascular Innovation
BRIEF

published on 07/25/2024 at 09:35, 3 months 27 days ago

TRiCares Secures $50 Million Series D Financing for Clinical Advancements

Clinical Trials Andera Partners TRiCares Series D Financing Heart Valve System
PRESS RELEASE

published on 07/25/2024 at 09:30, 3 months 27 days ago

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones
Andera Partners' portfolio company TRiCares secures $50 million in Series D Financing to support upcoming clinical milestones for its tricuspid heart valve replacement system, Topaz

Clinical Milestones Andera Partners TRiCares Series D Financing Topaz
BRIEF

published on 07/15/2024 at 09:35, 4 months 6 days ago

Amolyt Pharma, a Portfolio Company of Andera Partners, Acquired by AstraZeneca

Acquisition Biopharmaceuticals AstraZeneca Amolyt Pharma Rare Diseases
PRESS RELEASE

published on 07/15/2024 at 09:30, 4 months 6 days ago

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca
Andera Partners' portfolio company Amolyt Pharma has been acquired by AstraZeneca for $1.05 billion, enhancing AstraZeneca's Rare Disease late-stage pipeline and bone metabolism franchise

Acquisition Biopharmaceutical AstraZeneca Amolyt Pharma Andera Partners

Accesswire

Published on 11/21/2024 at 13:30, 29 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 44 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 53 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 59 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE